Visual Universitätsmedizin Mainz

Veröffentlichungen aus 2024

  • Bouwman E, Penson A, de Valk M, van den Oever SR, van der Pal HJH, van Dulmen-den Broeder E, Blijlevens NMA, Bresters D, Feijen EAM, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, Michel G, Ronckers CM, Teepen JC, Tissing WJE, Versluys BAB, Kremer LCM, Pluijm SMF, Loonen JJ; Dutch LATER Study Group and the PanCareFollowUp Consortium. Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study. Cancer. 2024 Apr 25. doi: 10.1002/cncr.35338. Epub ahead of print. PMID: 38662406.

  • Claessens JJM, Penson A, Bronkhorst EM, Kremer LCM, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Tissing WJE, van der Pal HJH, Blijlevens NMA, van den Heuvel-Eibrink MM, Versluys AB, Bresters D, Ronckers CM, Walraven I, Beerendonk CCM, Loonen JJ; Dutch LATER study group. Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS-LATER study. Cancer. 2024 Mar 15;130(6):995-1004. doi: 10.1002/cncr.35119. Epub 2023 Dec 6. PMID: 38055238.

  • de Beijer IAE, Hardijzer EC, Haupt R, Grabow D, Balaguer J, Bardi E, Nieto AC, Ciesiūniene A, Düster V, Filbert AL, Gsell H, Kapitančukė M, Ladenstein R, Langer T, Muraca M, van den Oever SR, Prikken S, Rascon J, Tormo MT, Uyttebroeck A, Vercruysse G, van der Pal HJH, Kremer LCM, Pluijm SMF; PanCareSurPass consortium. Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study. J Cancer Surviv. 2024 Mar 11. doi: 10.1007/s11764-024-01547-w. Epub ahead of print. Erratum for: J Cancer Surviv. 2023 Nov 28;: PMID: 38466480.

  • de Beijer IAE, van den Oever SR, Charalambous E, Cangioli G, Balaguer J, Bardi E, Alfes M, Cañete Nieto A, Correcher M, Pinto da Costa T, Degelsegger-Márquez A, Düster V, Filbert AL, Grabow D, Gredinger G, Gsell H, Haupt R, van Helvoirt M, Ladenstein R, Langer T, Laschkolnig A, Muraca M, Pluijm SMF, Rascon J, Schreier G, Tomášikova Z, Trauner F, Trinkūnas J, Trunner K, Uyttebroeck A, Kremer LCM, van der Pal HJH, Chronaki C; PanCareSurPass Consortium. IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey. J Med Internet Res. 2024 May 2;26:e49910. doi: 10.2196/49910. PMID: 38696248.

  • de Paula Silva N, Colombet M, Moreno F, Erdmann F, Dolya A, Piñeros M, Stiller CA, Steliarova-Foucher E; IICC-3 contributors. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Rev Panam Salud Publica. 2024 Feb 26;48:e11. doi: 10.26633/RPSP.2024.11. PMID: 38410357; PMCID: PMC10896122.

  • Filbert AL, Kremer L, Ladenstein R, Chronaki C, Degelsegger-Márquez A, van der Pal H, Bardi E, Uyttebroeck A, Langer T, Muraca M, Nieto AC, Rascon J, Bagnasco F, Beyer S, Te Dorsthorst J, Essiaf S, Galan AO, Kienesberger A, O'Brien K, Palau MC, Pluijm SMF, di Profio S, Saraceno D, Schneider C, Schreier G, Trinkūnas J, Zamberlan I, Grabow D, Haupt R; PanCareSurPass consortium. Scaling up and implementing the digital Survivorship Passport tool in routine clinical care - The European multidisciplinary PanCareSurPass project. Eur J Cancer. 2024 May;202:114029. doi: 10.1016/j.ejca.2024.114029. Epub 2024 Mar 19. PMID: 38513384.

  • Heymer EJ, Hawkins MM, Winter DL, Teepen JC, Sunguc C, Ronckers CM, Allodji RS, Alessi D, Sugden E, Belle FN, Bagnasco F, Byrne J, Bárdi E, Garwicz S, Grabow D, Jankovic M, Kaatsch P, Kaiser M, Michel G, Schindera C, Haddy N, Journy N, Česen Mazić M, Skinner R, Kok JL, Gunnes MW, Wiebe T, Sacerdote C, Maule MM, Terenziani M, Jakab Z, Winther JF, Lähteenmäki PM, Zadravec Zaletel L, Haupt R, Kuehni CE, Kremer LC, de Vathaire F, Hjorth L, Reulen RC. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Br J Cancer. 2024 Apr;130(6):976-986. doi: 10.1038/s41416-024-02577-y. Epub 2024 Jan 19. PMID: 38243010; PMCID: PMC10951281.

  • Lupo PJ, Chambers TM, Mueller BA, Clavel J, Dockerty JD, Doody DR, Erdmann F, Ezzat S, Filippini T, Hansen J, Heck JE, Infante-Rivard C, Kang AY, Magnani C, Malagoli C, Marcotte EL, Metayer C, Bailey HD, Mora AM, Ntzani E, Petridou ET, Pombo-de-Oliveira MS, Rashed WM, Roman E, Schüz J, Wesseling C, Spector LG, Scheurer ME. Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and Leukemia International Consortium. Int J Cancer. 2024 Feb 1;154(3):434-447. doi: 10.1002/ijc.34720. Epub 2023 Sep 11. PMID: 37694915; PMCID: PMC11034994.

  • Mogensen H, Tettamanti G, Frederiksen LE, Talbäck M, Härkonen J, Modig K, Pedersen C, Krøyer A, Hirvonen E, Kyrönlahti A, Heyman M, Holmqvist AS, Hasle H, Madanat-Harjuoja L, Malila N, Winther JF, Erdmann F, Feychting M. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden. Br J Cancer. 2024 Feb;130(2):260-268. doi: 10.1038/s41416-023-02499-1. Epub 2023 Nov 22. PMID: 37993542; PMCID: PMC10803319.

  • Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Deltour I, Erdmann F, Bonaventure A, Scheurer ME, Clavel J, Schüz J. Risk factors for childhood brain tumours: A systematic review and meta-analysis of observational studies from 1976 to 2022. Cancer Epidemiol. 2024 Feb;88:102510. doi: 10.1016/j.canep.2023.102510. Epub 2023 Dec 5. PMID: 38056243; PMCID: PMC10835339.

  • Penson A, Walraven I, Bronkhorst E, Grootenhuis MA, Maurice-Stam H, Loo MVH, Tissing WJE, van der Pal HJH, de Vries ACH, Bresters D, Ronckers CM, van den Heuvel-Eibrink MM, Neggers S, Versluys BAB, Louwerens M, Pluijm SMF, Blijlevens N, van Dulmen-den Broeder E, Kremer LCM, Knoop H, Loonen J; Dutch LATER study group. Different subtypes of chronic fatigue in childhood cancer survivors: A DCCSS LATER study. Pediatr Blood Cancer. 2024 Jun;71(6):e30951. doi: 10.1002/pbc.30951. Epub 2024 Mar 31. PMID: 38556733.

  • Scholz-Kreisel P, Becker C, Kaiser M, Mahmoudpour SH, Voigt M, Ressing M, Blettner M, Calaminus G, Baust K, Scholtes C, Zimmermann M, Zeissig SR, Schmidberger H, Karle H, Meyer-Oldenburg S, Kaatsch P, Spix C. Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR. Cancer Causes Control. 2024 Jan;35(1):33-41. doi: 10.1007/s10552-023-01760-5. Epub 2023 Aug 2. PMID: 37530985; PMCID: PMC10764383.

  • Scobioala S, Parfitt R, Matulat P, Byrne J, Langer T, Troschel FM, Hesping AE, Clemens E, Kaatsch P, Grabow D, Kaiser M, Spix C, Kremer LC, Calaminus G, Baust K, Kuehni CE, Weiss A, Strebel S, Kuonen R, Elsner S, Haupt R, Garré ML, Gruhn B, Kepak T, Kepakova K, Winther JF, Kenborg L, Rechnitzer C, Hasle H, Kruseova J, Luks A, Lackner H, Bielack S, Beck JD, Jürgens H, van den Heuvel-Eibrink MM, Zolk O, Eich HT, Am Zehnhoff-Dinnesen A; PanCareLIFE Consortium. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium. Int J Cancer. 2024 Jan 15;154(2):320-331. doi: 10.1002/ijc.34732. Epub 2023 Sep 15. PMID: 37715472.

  • Wellbrock M, Voigt M, Ronckers C, Grabow D, Spix C, Erdmann F. Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980-2019: An analysis of 40 years based on data from the German Childhood Cancer Registry. Pediatr Blood Cancer. 2024 Jun;71(6):e30954. doi: 10.1002/pbc.30954. Epub 2024 Mar 26. PMID: 38532243.

Veröffentlichungen aus 2023

  • Brackmann LK, Foraita R, Schwarz H, Poplawski A, Hankeln T, Galetzka D, Zahnreich S, Spix C, Blettner M, Schmidberger H, Marron M. Self-administered questionnaire assessing childhood cancer treatments and associated risks for adverse health outcomes - The KiKme study. Front Oncol. 2023;13:1150629.

  • de Baat EC, Feijen EAM, Reulen RC, Allodji RS, Bagnasco F, Bardi E, Belle FN, Byrne J, van Dalen EC, Debiche G, Diallo I, Grabow D, et al. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023;41: 96-106.

  • Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, Bárdi E, Bagnasco F, Gudmundsdottir T, Skinner R, Michel G, Byrne J, et al. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer 2023;129: 426-40.

  • Ernst M, Werner AM, Brähler E, Wild PS, Faber J, Merzenich H, Beutel ME. Posttraumatic growth after childhood cancer: Psychometric evaluation of a five-item short form and associations with mental health. J Psychosom Res 2023;164: 111099.

  • Grandt CL, Brackmann LK, Foraita R, Schwarz H, Hummel-Bartenschlager W, Hankeln T, Kraemer C, Zahnreich S, Drees P, Mirsch J, Spix C, Blettner M, Schmidberger H, Binder H, Hess M, Galetzka D, Marini F, Poplawski A, Marron M. Gene expression variability in long-term survivors of childhood cancer and cancer-free controls in response to ionizing irradiation. Mol Med. 2023;29(1):41.

  • Kyrönlahti A, Erdmann F, Feychting M, Frederiksen LE, Hirvonen E, Korhonen LM, Krøyer A, Mader L, Malila N, Mogensen H, Pedersen C, Talbäck M, Taskinen M, Winther JF, Madanat-Harjuoja L, Pitkäniemi J. Income disparities between adult childhood cancer survivors and their peers-A register-based cohort study from the SALiCCS research programme. Cancer Med. 2023. doi: 10.1002/cam4.6218. Online ahead of print.

  • Maas A, Maurice-Stam H, van der Aa-van Delden AM, van Dalen EC, van Dulmen-den Broeder E, Tissing WJE, et al. Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study. J Cancer Surviv. 2023. doi: 10.1007/s11764-023-01394-1. Online ahead of print.

  • Ressing M, Becker C, Müller C, Mahmoudpour SH, Calaminus G, Langer T, Erdmann F, Voigt M, Kaiser M, Kaatsch P, Blettner M, Spix C. Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors. Cancer Rep (Hoboken). 2023;6(5):e1811.

  • Reulen RC, Winter DL, Diallo I, Veres C, Llanas D, Allodji RS, et al. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study. J Clin Oncol. 2023;JCO2202045.

  • Russo A, Blettner M, Merzenich H, Wollschlaeger D, Erdmann F, Gianicolo E. Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019. International journal of cancer Journal international du cancer 2023;152: 913-20.

  • Stolze J, Raber-Durlacher JE, Loonen JJ, Teepen JC, Ronckers CM, Tissing WJE, et al. Self-reported outcomes on oral health and oral health-related quality of life in long-term childhood cancer survivors-A DCCSS-LATER 2 Study. Support Care Cancer. 2023;31(6):344.

  • Sunguc C, Hawkins MM, Winter DL, Dudley IM, Heymer EJ, Teepen JC, Allodji RS, Belle FN, Bagnasco F, Byrne J, Bárdi E, Ronckers CM, et al. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. British journal of cancer 2023;128: 80-90.

  • van den Oever SR, de Beijer IAE, Kremer LCM, Alfes M, Balaguer J, Bardi E, Nieto AC, Cangioli G, Charalambous E, Chronaki C, Costa T, Degelsegger A, et al. Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study. J Cancer Surviv 2023.

  • Wellbrock M, Spix C, Ronckers CM, Grabow D, Filbert AL, Wollschläger D, Erdmann F. Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register-study based on data from the German Childhood Cancer Registry. Int J Cancer. 2023. doi: 10.1002/ijc.34556. Online ahaed of print.

  • Zahnreich S, Yusifli K, Poplawski A, Eckhard LS, Mirsch J, Hankeln T, Galetzka D, Marron M, Scholz-Kreisel P, Spix C, Schmidberger H. Replication stress drives chromosomal instability in fibroblasts of childhood cancer survivors with second primary neoplasms. DNA Repair (Amst) 2023;122: 103435.

Veröffentlichungen aus 2022

  • Abele M, Voggel S, Bremensdorfer C, Spix C, Erdmann F, Kuhlen M, et al. Incidence and characteristics of primary lung malignancies in childhood in Germany– an analysis of population-based data from German cancer registries. Pediatric Blood & Cancer. 2022;e29744.

  • Achajew A, Brecht IB, Radespiel-Tröger M, Meyer M, Metzler M, Bremensdorfer C, et al. Rare pediatric tumors in Germany – not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer Registry. European Journal of Pediatrics. 2022;181(7):2723-2730.

  • Betzmann D, Döring M, Blumenstock G, Erdmann F, Grabow D, Lang P, et al. Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients. Transplant Cell Ther. 2022;28(7):355.e1-355.e9.

  • Borkhardt A, Schüz J, Trübenbach C, Wellbrock M, Spix C, Erdmann F. Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic. Leukemia. 2022;36(12):2908-2911.

  • Botta L, Gatta G, Capocaccia R, Stiller C, Canete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncology. 2022;23(12):1525-1536.

  • Brackmann LK, Foraita R, Schwarz H, Galetzka D, Zahnreich S, Hankeln T, Löbrich M, Poplawski A, Grabow D, Blettner M, Schmidtberger H, Marron M. Late health effects and changes in lifestyle factors after cancer in childhood with and without subsequent second primary cancers - the KiKme case-control study. Front Oncol. 2022;12:1037276.

  • Byrne J, Schmidtmann I, Rashid H, Hagberg O, Bagnasco F, Bardi E, et al. Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. International journal of cancer Journal international du cancer. 2022;150(3):406-19.

  • Chronaki C, Charalambous E, Cangioli G, Schreier G, van den Oever S, van der Pal H, Kremer L, Uyttebroeck A, van den Bosch B, Trinkunas J, Rascon J, Ladenstein R, Düster V, Bardi E, Walz D, Filbert A-L, Grabow D, et al. Factors Influencing Implementation of the Survivorship Passport: The IT Perspective. Stud Health Technol Inform. 2022;293:161-168.

  • de Baat E, Feijen EAM, Reulen RC, Allodji RS, Bagnasco F, Bardi E, Belle FN, Byrne J, van Dalen EC, Debiche G, Diallo I, Grabow D, et al. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study. J Clin Oncol. 2022;JCO2102944. ahead of print.

  • Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, Bardi E, Bagnasco F, Gudmundsdottir T, Skinner R, Michel G, Byrne J, Øfstaas H, Jankovic M, Mazic MC, Mader L, Loonen J, Garwicz S, Wiebe T, Alessi D, Allodji RS, Haddy N, Grabow D, Kaatsch P, Kaiser M, et al. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer. 2022. ahead of print.

  • Erdmann F, Raaschou-Nielsen O, Hvidtfeldt UA, Ketzel M, Brandt J, Khan J, Schüz J, Sørensen M. Residential road traffic and railway noise and risk of childhood cancer: A nationwide register-based case-control study in Denmark. Environ Res. 2022; 212(Pt A):113180.

  • Erdmann F, Spix C, Schrappe M, Borkhardt A, Schüz J. Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry. Lancet Reg Health Eur. 2022;17:100398.

  • Frederiksen LE, Erdmann F, Mader L, Mogensen H, Pedersen C, Kenborg L, et al. Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme. Lancet Psychiatry. 2022:9(1):35-45.

  • Galetzka D, Bock J, Wagner L, Dittrich M, Sinizyn O, Ludwig M, et al. Hypermethylation of RAD9A intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation. EXCLI J. 2022;21:117-43.

  • Grandt CL, Brackmann LK, Poplawski A, Schwarz H, Hummel-Bartenschlager W, Hankeln T, Kraemer C, Marini F, Zahnreich S, Schmitt I, Drees P, Mirsch J, Grabow D, Schmidtberger H, Binder H, Hess M, Galetzka D, Marron M. Radiation-response in primary fibroblasts of long--term survivors of childhood cancer with and without second primary neoplasms: the KiKme study. Mol. Med. 2022;28(1):105.

  • Juhnke BO, Gessi M, Gerber NU, Friedrich C, Mynarek M, von Bueren AO, et al. Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol. 2022;24(1):127-37.

  • Kube SJ, Blattmann C, Bielack SS, Kager L, Kaatsch P, Kuhne T, Sorg B, Kevric M, Jabar S, Hallmen E, Sparber-Sauer M, Klingebiel T, Koscielniak E, Dirksen U, Hecker-Nolting S, Gerss JWO. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer. 2022;128(9):1787-1800.

  • Loizou L, Demetriou A, Erdmann F, Borkhardt A, Brozou T, Sharp L, McNally. Patterns and temporal trends in the incidence of childhood and adolescence cancer in Cyprus 1998-2017: A population-based study from the Cyprus Paediatric Oncology Registry. Cancer Epidemiol. 2022;80:102239.

  • Marx A, Spix C, Vokuhl C. Pathological Aspects of Mediastinal Tumors in Children and Adolescents. In: Schneider DT, Brecht IB, Olson TA, Ferrari A, editors. Rare Tumors in Children and Adolescents. Cham: Springer International Publishing; 2022. p. 137-48.

  • Merzenich H, Baaken D, Schneider A, Neu MA, Wingerter A, Faber J, Wild P, Spix C. Mortality risk among 5-year survivors of childhood cancer in Germany - Results from the CVSS study (Cardiac and Vascular late Sequalae in long-term Survivors of childhood cancer study). Int J Cancer. 2022;150(1):67-72.

  • Onyije FM, Olsson A, Baaken D, Erdmann F, Stanulla M, Wollschläger D, et al. Environmental Risk Factors for Childhood Acute Lymphoblastic Leukemia: An Umbrella Review. Cancers. 2022;14(2):382.

  • Russo A, Blettner M, Merzenich H, Wollschläger D, Erdmann F, Gianicolo E. Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019. Int J Cancer. 2022; ahead of print.

  • Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, Erdmann F, Karow A, Metzler M, Suttorp M. Patient-reported long-term outcome following allogenic hematopoietic stem cell transplantaton in pediatric chronic myeloid leukemia. Front Oncol. 2022;12:963223.

  • Schüz J, Borkhardt A, Bouaoun L, Erdmann F. The impact of the COVID-19 pandemic on the future incidence of acute lymphoblastic leukaemia in children: Projections for Germany under a COVID-19 related scenario. Int J Cancer. 2022;151(1):153-5.

  • Sørensen GV, Albieri V, Holmqvist AS, Erdmann F, Mogensen H, Talbäck M, et al. Long-term risk of hospitalization for somatic diseases among survivors of childhood acute lymphoblastic leukemia. JNCI Cancer Spectrum. 2022;6(2):pkac029

  • Sørensen GV, Belmonte F, Erdmann F, Mogensen H, Albieri V, Holmqvist AS, et al. Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971-2008 in Denmark, Finland, and Sweden: A population-based cohort study. Pediatr Blood Cancer. 2022;69(1):e29356.

  • Sunguc C, Hawkins MM, Winter DL, Dudley IM, Heymer EJ, Teepen JC, Allodji RS, Belle FN, Bagnasco F, Byrne J, Bardi E, Ronckers CM, Haddy N, Gudmundsdottir T, Garwicz S, Jankowic M, van der Pal HJH, Mazic MC, Schindera C, Grabow D, Maule M, Kaatsch P, Kaiser M, et al. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Br J Cancer. 2022. ahead of print.

  • Trama A, Bernasconi A, Botta L, Byrne J, Grabow D, Reulen RC, Calaminus G, Terenziani. Late mortality reduction among survivors of germ cell tumours in childhood and adolescence in Europe: A report from the PanCareSurFup cohort. Pediatr Blood Cancer. 2022;69(12):e29991.

  • Wellbrock M, Zeeb H, Spix C, Grabow D, Borkhardt A, Erdmann F. Survival in Children Below the Age of 15 Years With Leukemia: Temporal Patterns in Eastern and Western Germany Since German Reunification. HemaSphere. 2022;6(8):e755

  • Zolk O, von dem Knesebeck A, Graf N, Simon T, Hero B, Abdul-Khaliq H, et al. Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study. JMIR research protocols. 2022;11(2):e27898.

Veröffentlichungen aus 2021

  • Arnold N, Merzenich H, Wingerter A, Schulz A, Schneider A, Prochaska JH, et al. Promotion of Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-Term Survivors. J Am Heart Assoc. 2021;10(5):e015609.

  • Betzmann D, Doering M, Blumenstock G, Erdmann F, Grabow D, Lang P, et al. Impact of pre-transplant serum-IGF-1 on hematopoietic stem cell transplantation outcome in pediatric cancer patients. Hormone Research in Paediatrics. 2021;94(Suppl 1).

  • Calaminus G, Baust K, Berger C, Byrne J, Binder H, Casagranda L, et al. Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE. JMIR research protocols. 2021;10(1):e21851.

  • Dutzmann CM, Spix C, Popp I, Kaiser M, Erdmann F, Erlacher M, et al. Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia - A Nationwide Register-Based Cohort Study in Germany. J Clin Oncol. 2021;JCO210101495.

  • Erdmann F, Frederiksen LE, Bonaventure A, Mader L, Hasle H, Robison LL, et al. Childhood cancer: Survival, treatment modalities, late effects and improvements over time. Cancer Epidemiology. 2021;71(Pt B):101733.

  • Erdmann F, Frederiksen LE, Mogensen H, Pedersen C, Mader LA, Talbäck M, et al. Cohort Profile: The Socioeconomic Consequences in Adult Life After Childhood Cancer in Scandinavia (SALiCCS) Reasearch Programme. Frontiers in Oncology. 2021;11:752948.

  • Erdmann F, Spix C, Katalinic A, Christ M, Folkerts J, Hansmann J, et al. Krebs in Deutschland für 2017/2018. Robert-Koch-Institut.

  • Erdmann F, Wellbrock M, Trübenbach C, Spix C, Schrappe M, Schüz J, et al. Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: Evidence from the German Childhood Cancer Registry and a qualitative survey. The Lancet Regional Health - Europe. 2021;9:100188.

  • Feijen EAM, van Dalen EC, van der Pal HJH, Reulen RC, Winter DL, Keuhni CE, et al. Increased risk of cardiac ischaemia in a pan-European cohort of 36,205 childhood cancer survivors: a PanCareSurFup study. Heart. 2021;107(1):33-40.

  • Frederiksen LE, Pedersen C, Mogensen H, Mader L, Bautz A. Talbäck M, et al. Employment status and occupational positions of childhood cancer survivors from Denmark, Finland and Sweden: A Nordic register-based cohort study from the SALiCCS research programme. Lancet Reg Health Eur. 2021;12:100258.

  • Gnekow AK, Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, et al. Doubling recruitment of pediatric low-grade glioma within two decades does not change outcome – report from the German LGG studies (Verdopplung der Rekrutierungszahl niedrig-gradiger Gliome des Kindes- und Jugendalters innerhalb von 20 Jahren ändert die Überlebenschancen nicht – Bericht aus den deutschen LGG-Studien). Klinische Pädiatrie. 2021;233(3):107-122.

  • Hilgendorf I, Bergelt C, Bokemeyer C, Kaatsch P, Seifart U, Stein A, et al. Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors. Oncology research and treatment. 2021:1-6.

  • Hippert F, Desing L, Diez S, Witowski A, Bernbeck B, Abele M, et al. Rare Tumors in Children and Adolescents–the STEP Working Groupʼs Evolution to a Prospective Registry. Klinische Pädiatrie. Ahead of print.

  • Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schuz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer epidemiology. 2021;71(Pt B):101662.

  • Juhnke BO, Gessi M, Gerber NU, Friedrich C, Mynarek M, von Büren A, et al. Treatment of Embryonal Tumours with Multi-layered Rosettes (ETMR) with carboplatin/etoposide Induction and High-dose Chemotherapy within the Prospective P-HIT/HIT2000 Trial. Neuro-Oncology. 2021;noab100.

  • Kaatsch P, Byrne J, Campbell H, O´Brien K, am Zehnhoff-Dinnesen A, Calaminus G, et al. Managing a pan-European consortium on late effects among long-term survivors of childhood and adolescent cancer - the PanCareLIFE project. International Journal of Environmental Research and Public Health. 2021;18(8):3918.

  • Loizou L, Demetriou A, Erdmann F, Borkhardt A, Brozou T, Sharp L, et al. Increasing incidence and survival of paediatric and adolescent thyroid cancer in Cyprus 1998-2017: A population-based study from the Cyprus Pediatric Oncology Registry. Cancer Epidemiol. 2021; 74:101979.

  • Mader L, Frederiksen LE, Bidstrup PE, Hargreave M, Kjær SK, Kuehni CE, et al. Hospital Contacts for Psychiatric Disorders in Parents of Children With Cancer in Denmark. JNCI Cancer Spectr. 2021;5(3):pkab036.

  • Merzenich H, Baaken D, Schneider A, Neu MA, Wingerter A, Faber J, et al. Mortality risk among 5-year survivors of childhood cancer in Germany-Results from the CVSS study (Cardiac and Vascular late Sequelae in long-term Survivors of childhood cancer study). Int J Cancer. 2021; Epub - ahead of print.

  • Mogensen H, Modig K, Talbäck M, Erdmann F, Heyman M, Feychting M, et al. Number of siblings and survival from childhood leukaemia: a national register-based cohort study from Sweden. British Journal of Cancer. 2021;125(1):112-118.

  • Neu MA, Schlecht J, Schmidt MF, Robinson AL, Spix C, Grabow D, et al. Mental health and health-related quality of life in preschool-aged childhood cancer survivors. Results of the prospective cohort study ikidS-OEVA. Pediatric Blood and Cancer. 2021;e29039.

  • Pedersen LH, Erdmann F, Aalborg GL, Hjalgrim LL, Larsen HB, Schmiegelow K, et al. Socioeconomic position and prediagnostic health care contacts in children with cancer in Denmark: a nationwide register study. BMC Cancer. 2021;21(1):1104.

  • Reschke M, Biewald E, Bronstein L, Brecht IB, Dittner-Moormann S, Driever F, et al. Eye tumors in childhood as first sign of tumor predisposition syndromes. Cancers. 2021;13(8):1876.

  • Schmidt JA, Hornhardt S, Erdmann F, Sánchez-García I, Schüz J, Ziegelberger G. Risk Factors for Childhood Leukaemia: Radiation and Beyond. Front Public Health. 2021;9:805757.

  • Schundeln MM, Lange T, Knoll M, Spix C, Brenner H, Bozorgmehr K, et al. Methods of spatial cluster detection in rare childhood cancers: Benchmarking data and results from a simulation study on nephroblastoma. Data Brief. 2021;34:106683.

  • Schundeln MM, Lange T, Knoll M, Spix C, Brenner H, Bozorgmehr K, et al. Statistical methods for spatial cluster detection in childhood cancer incidence: A simulation study. Cancer epidemiology. 2021;70:101873.
  • van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, et al. Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE). Human Reproduction. 2021;36(6):1561-1573.

  • Van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, et al. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Human reproduction (Oxford, England). 2021;36(4):1120-1133.

  • van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, et al. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel). 2021;13(18):4598.

  • Wellbrock M, Spix C, Grabow D, Borkhardt A, Zeeb H, Erdmann F. 28-year incidence and time trends of childhood leukaemia in former East Germany compared to West Germany after German reunification: A study from the German Childhood Cancer Registry. Cancer Epidemiology. 2021;73:101968.

  • Wellbrock M, Spix C, Grabow D, Erdmann F. Epidemiologie von Krebserkrankungen im Kindes- und Jugendalter (Epidemiology of cancer in children and adolescents). Der Onkologe. 2021;27:401-409.

Veröffentlichungen aus 2020

  • Becker C, Graf N, Grabow D, Creutzig U, Reinhardt D, Weyer-Elberich V, et al. Early deaths from childhood cancer in Germany 1980-2016. Cancer epidemiology. 2020;65:101669.

  • Coktu S, Spix C, Kaiser M, Beygo J, Kleinle S, Bachmann N, et al. Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study. British journal of cancer. 2020;123(4):619-23.

  • Clemens E, Broer L, Langer T, Uitterlinden AG, de Vries ACH, van Grotel M, et al. Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. Pharmacogenomics J. 2020;20(2):294-305.

  • Erdmann F, Hvidtfeldt UA, Feychting M, Sorensen M, Raaschou-Nielsen O. Is the risk of childhood leukaemia associated with socioeconomic measures in Denmark?: A nationwide register-based case-control study. International journal of cancer Journal international du cancer. 2020.

  • Erdmann F, Hvidtfeldt UA, Sorensen M, Raaschou-Nielsen O. Socioeconomic differences in the risk of childhood central nervous system tumors in Denmark: a nationwide register-based case-control study. Cancer causes & control : CCC. 2020;31(10):915-29.

  • Feijen EAM, van Dalen EC, van der Pal HJH, Reulen RC, Winter DL, Keuhni CE, et al. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. Heart. 2020.

  • Galetzka D, Muller T, Dittrich M, Endres M, Kartal N, Sinizyn O, et al. Correction to: Molecular karyotyping and gene expression analysis in childhood cancer patients. Journal of molecular medicine (Berlin, Germany). 2020;98(11):1657.

  • Gebauer J, Baust K, Bardi E, Grabow D, Stein A, van der Pal HJ, et al. Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work. Oncology research and treatment. 2020;43(3):61-9.

  • Hvidtfeldt UA, Erdmann F, Urhoj SK, Brandt J, Geels C, Ketzel M, et al. Air pollution exposure at the residence and risk of childhood cancers in Denmark: A nationwide register-based case-control study. EClinicalMedicine. 2020;28:100569.

  • Hvidtfeldt UA, Erdmann F, Urhoj SK, Brandt J, Geels C, Ketzel M, Frohn LM, Christensen JH, Sorensen M, Raaschou-Nielsen O. Residential Exposure to PM2.5 Components and Risk of Childhood Non-Hodgkin Lymphoma in Denmark: A Nationwide Register-Based Case-Control Study. International journal of environmental research and public health. 2020;17(23).

  • Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, et al. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020;32:106227.

  • Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, et al. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. European journal of cancer. 2020;138:212-24.

  • Mazzei-Abba A, Folly CL, Coste A, Wakeford R, Little MP, Raaschou-Nielsen O, et al. Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives. Journal of radiological protection : official journal of the Society for Radiological Protection. 2020;40(1):R1-R23.

  • Moser O, Zimmermann M, Meyer U, Klapper W, Oschlies I, Schrappe M, et al. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group. Haematologica. 2020.

  • Reulen RC, Wong KF, Bright CJ, Winter DL, Alessi D, Allodji RM, et al. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Gut. 2020.

  • Stanulla M, Erdmann F, Kratz CP. Risikofaktoren für Krebserkrankungen im Kindes- und Jugendalter. Monatsschr Kinderh. 2020;169(1):30-8.

  • Stern H, Seidenbusch M, Hapfelmeier A, Meierhofer C, Naumann S, Schmid I, et al. Increased Cancer Incidence Following up to 15 Years after Cardiac Catheterization in Infants under One Year between 1980 and 1998-A Single Center Observational Study. Journal of clinical medicine. 2020;9(2).

  • Zahnreich S, Poplawski A, Hartel C, Eckhard LS, Galetzka D, Hankeln T, et al. Spontaneous and Radiation-Induced Chromosome Aberrations in Primary Fibroblasts of Patients With Pediatric First and Second Neoplasms. Frontiers in oncology. 2020;10:1338.

Veröffentlichungen aus 2019

  • Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. European journal of cancer. 2019;117:71-83.

  • Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, et al. Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study. JMIR research protocols. 2019;8(3):e11868.

  • Gebauer J, Calaminus G, Baust K, Grabow D, Kaatsch P, Langer T. Beobachtung von Langzeitnebenwirkungen bei Überlebenden kindlicher Krebserkrankungen. Forum. 2019.

  • Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry - Annual Report 2018 (1980-2017). Mainz: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz; 2019.

  • Kraywinkel K, Spix C. Epidemiologie primärer Hirntumoren bei Kindern und Erwachsenen in Deutschland. Der Onkologe 2019;25:5–9.

  • Mazzei-Abba A, Folly CL, Coste A, Wakeford R, Little MP, Raaschou-Nielsen O, et al. Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives. Journal of radiological protection : official journal of the Society for Radiological Protection. 2019;40(1):R1-r23.

  • Scholtes C, Baust K, Weinhold L, Creutzig U, Gnekow A, Hinz A, et al. Health status, Health-Related Quality of Life and Socio-economic Outcome in Childhood Brain Tumor Survivors: a German Cohort Study. Neuro Oncol. 2019.

Veröffentlichungen aus 2018

  • Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, et al. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. Journal of the National Cancer Institute. 2018;110(6):649-60.

  • Byrne J, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, et al. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. European journal of cancer. 2018;103:238-48.

  • Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, et al. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. European journal of cancer. 2018;103:227-37.

  • Dantonello TM, Vokuhl C, Scheer M, Sparber-Sauer M, Stegmaier S, Seitz G, et al. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis? Virchows Archiv : an international journal of pathology. 2018;472(3):441-9.

  • Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Munzel T, et al. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J. 2018;39(17):1555-62.

  • Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bardi E, et al. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. Journal of the National Cancer Institute. 2018;110(2).

  • Gebauer J, Lehnert H, Schmid SM, Spix C, Stein A, Langer T. [Late effects following childhood cancer treatment : A special challenge for transition medicine]. Der Internist. 2018;59(11):1157-62.

  • Gebauer J, Spix C, Brabant G, Langer T. Endokrine Spätfolgen nach onkologischer Therapie im Kindesalter. Der Onkologe. 2018;24(10):790-6.

  • Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. European journal of epidemiology. 2018;33(3):335-49.

  • Grabow D, Kaatsch P. Europäische PanCare-Studien zu Spätfolgen nach Krebs im Kindes- und Jugendalter. Der Onkologe. 2018;24(10):754-9.

  • Jankovic M, Haupt R, Spinetta JJ, Beck JD, Byrne J, Calaminus G, et al. Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016). J Cancer Surviv. 2018;12(5):647-50.

  • Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry - Annual Report 2017 (1980-2016). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz; 2018.

  • Langer T, Grabow D, Kaatsch P, Creutzig U, Eggert A, Escherich G, et al. [Long-Term Follow-Up in Childhood Cancer Survivors - Position paper 2018 of the working group "long-term follow-up" of the Society of Pediatric Oncology and Hematology (GPOH) on long-term surveillance, long-term follow-up and late effect evaluation in pediatric oncology patients]. Klinische Padiatrie. 2018;230(6):291-8.

  • Mensah J, Kowalski C, Grabow D, Spix C, Kaatsch P. Möglichkeiten zur Versorgungsforschung bei Überlebenden nach Krebs im Kindesalter. Onkologie heute. 2018(8/2018).

  • Panova-Noeva M, Neu MA, Eckerle S, Spix C, Schneider A, Schmidtmann I, et al. Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer. Clinical research in cardiology : official journal of the German Cardiac Society. 2018.

  • Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, et al. Second primary cancer after childhood cancer in Germany 1980-2014 – a registry based analysis Deutsches Ärzteblatt. 2018.

  • Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, et al. Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014. Deutsches Arzteblatt international. 2018;115(23):385-92.

  • Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Pineros M, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study. The lancet oncology. 2018;19(9):1159-69.

  • van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol. BMC cancer. 2018;18(1):930.

  • van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, et al. Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). JMIR research protocols. 2018;7(9):e10824.


-------------------------------------------------------------------------------------------------

Archivierte Publikationen von 2001 bis 2016 finden Sie hier im Archiv.